Delivering on the promise of precision cancer medicine.
作者信息
Berger Michael F, Van Allen Eliezer M
机构信息
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
出版信息
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
Abstract
摘要
相似文献
1
Delivering on the promise of precision cancer medicine.
Genome Med. 2016 Oct 25;8(1):110. doi: 10.1186/s13073-016-0373-1.
2
Personalized Medicine: Genomics Trials in Oncology.
Trans Am Clin Climatol Assoc. 2015;126:133-43.
3
Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1179-1181. doi: 10.1080/17474124.2018.1535897. Epub 2018 Oct 17.
4
New ESMO scale ranks mutations as cancer medicine targets.
Lancet Oncol. 2018 Oct;19(10):e513. doi: 10.1016/S1470-2045(18)30664-8. Epub 2018 Aug 31.
5
Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
JAMA Oncol. 2016 Jan;2(1):13-4. doi: 10.1001/jamaoncol.2015.4503.
6
Paul Workman: Drugging the Cancer Genome.
Trends Cancer. 2016 Oct;2(10):544-548. doi: 10.1016/j.trecan.2016.10.004.
7
Giving Up on Precision Oncology? Not So Fast!
Clin Transl Sci. 2017 May;10(3):128-129. doi: 10.1111/cts.12457. Epub 2017 Feb 21.
8
Precision oncology: an overview.
J Clin Oncol. 2013 May 20;31(15):1803-5. doi: 10.1200/JCO.2013.49.4799. Epub 2013 Apr 15.
9
Precision medicine in pediatric oncology.
Curr Opin Pediatr. 2018 Feb;30(1):17-24. doi: 10.1097/MOP.0000000000000570.
10
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
Am Soc Clin Oncol Educ Book. 2014:71-6. doi: 10.14694/EdBook_AM.2014.34.71.
引用本文的文献
1
A Systematic Approach to Optimize the Implementation of Precision Oncology in Clinical Practice: A Meeting Proceeding.
J Immunother Precis Oncol. 2024 Aug 19;7(3):210-216. doi: 10.36401/JIPO-23-41. eCollection 2024 Aug.
2
Hallmarks of cancer resistance.
iScience. 2024 May 15;27(6):109979. doi: 10.1016/j.isci.2024.109979. eCollection 2024 Jun 21.
3
Bioinformatics analyses of combined databases identify shared differentially expressed genes in cancer and autoimmune disease.
J Transl Med. 2023 Feb 10;21(1):109. doi: 10.1186/s12967-023-03943-9.
4
Great future or greedy venture: Precision medicine needs philosophy.
Health Sci Rep. 2021 Sep 14;4(3):e376. doi: 10.1002/hsr2.376. eCollection 2021 Sep.
5
Applying Precision Oncology Principles in Radiation Oncology.
JCO Precis Oncol. 2018 May 14;2. doi: 10.1200/PO.18.00034. eCollection 2018.
6
Assessing the Training and Research Environment for Genomics, Bioinformatics, and Immunology in Radiation Oncology.
JCO Clin Cancer Inform. 2018 Dec;2:1-9. doi: 10.1200/CCI.18.00045.
7
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.
Med Res Rev. 2018 Jan;38(1):325-376. doi: 10.1002/med.21463. Epub 2017 Sep 1.
本文引用的文献
1
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
Genome Med. 2016 Jul 26;8(1):79. doi: 10.1186/s13073-016-0333-9.
2
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study.
Genet Med. 2016 Oct;18(10):1011-9. doi: 10.1038/gim.2015.207. Epub 2016 Feb 11.
3
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth.
JAMA. 2015 Sep 1;314(9):913-25. doi: 10.1001/jama.2015.10080.
4
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.
N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309.
5
CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record.
J Am Med Inform Assoc. 2015 Nov;22(6):1231-42. doi: 10.1093/jamia/ocv065. Epub 2015 Jul 3.
6
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
7
Integrative clinical genomics of advanced prostate cancer.
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
8
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
J Mol Diagn. 2015 May;17(3):251-64. doi: 10.1016/j.jmoldx.2014.12.006. Epub 2015 Mar 20.
9
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.
Nat Med. 2014 Jun;20(6):682-8. doi: 10.1038/nm.3559. Epub 2014 May 18.
10
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
N Engl J Med. 2013 Jun 20;368(25):2385-94. doi: 10.1056/NEJMoa1214886. Epub 2013 Jun 1.
Zotero 插件